The multiplicity of subclasses, each targeting distinct molecular nodes, ranging from insulin signaling and androgen synthesis to inflammatory and OS pathways, positions flavonoids as uniquely suited for addressing the multifactorial pathophysiology of PCOS. The gene discussed is INS; the disease is polycystic ovary syndrome.